A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.
Srila GopalQing LuJoshua J ManWendy BaurSitara P RaoLev LitichevskiyMalvina PapanastasiouAmanda L CreechKatherine C DeRuffJames MullahooAdam OfficerShawn B EgriDesiree DavisonJacob D JaffeIris Z JaffePublished in: Blood advances (2019)